Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126483481 | 12648348 | 1 | I | 201606 | 20160803 | 20160812 | 20160812 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-064558 | BRISTOL MYERS SQUIBB | 27.90 | YR | M | Y | 0.00000 | 20160812 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126483481 | 12648348 | 1 | PS | SPRYCEL | DASATINIB | 1 | Oral | 100 MG, QD | 21986 | 100 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126483481 | 12648348 | 1 | Chronic myeloid leukaemia |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126483481 | 12648348 | Decreased appetite | |
126483481 | 12648348 | Fatigue | |
126483481 | 12648348 | Nausea | |
126483481 | 12648348 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126483481 | 12648348 | 1 | 20160622 | 201607 | 0 |